Pfizer’s big fat fail 12/1/23
CNBC
Pfizer shares sinking to March 2020 lows after the company halted its twice-daily weight loss pill. Just how big of a setback is this for the pharma heavyweight’s entry into the obesity drug race? The Fast Money traders debate.
Fast Money Disclaimer